Interventional AI-Human Collaboration for Liver Tumor Diagnosis

NARecruitingINTERVENTIONAL
Enrollment

10,000

Participants

Timeline

Start Date

September 1, 2025

Primary Completion Date

October 15, 2025

Study Completion Date

October 20, 2025

Conditions
Hepatocellular Carcinoma (HCC)Intrahepatic Cholangiocarcinoma (Icc)Hepatic MetastasisHepatic HemangiomaCystFocal Nodular Hyperplasia
Interventions
DIAGNOSTIC_TEST

AI-human collaboration for CE-CTs diagnosis

The system automatically processes all eligible same-day scans and generates results for review the following day. To maintain efficient AI-human collaboration while preserving the standard clinical workflow, the conventional radiological interpretation process remains unchanged (first-line radiologists provide initial reports followed by senior radiologists' review). A dedicated senior radiologist then evaluates any discordances between AI findings and primary radiological report. For complex cases, the review process escalates to a consensus review panel (i.e., pre-designated senior radiologists, Multidisciplinary Team (MDT)). The MDT can recommend clinical interventions including follow-up (e.g., additional imaging examinations, active surveillance), surgical procedures, or adjustments to adjuvant therapy (initiation or modification of treatment regimens). All discordant cases and their outcomes are systematically documented for longitudinal tracking and follow-up analysis.

Trial Locations (1)

110004

RECRUITING

Shengjing Hospital of China Medical University, Shenyang

All Listed Sponsors
lead

Shengjing Hospital

OTHER

NCT07153783 - Interventional AI-Human Collaboration for Liver Tumor Diagnosis | Biotech Hunter | Biotech Hunter